Dr. Camille Kotton is the clinical director of the Transplant Infectious Disease and Immunocompromised Host Program at the Massachusetts General Hospital, and associate professor of medicine, Harvard Medical School. She was chair of the Infectious Disease Community of Practice of the American Society of Transplantation (2012-2018). From 2007 to 2013, she was president of the Transplant Infectious Disease Section of the Transplantation Society. Highlights of her time as president include the development of international guidelines on cytomegalovirus (CMV) management after solid organ transplant, published in Transplantation (2010, 2013, 2018). Her clinical interests include cytomegalovirus, vaccines, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting.